藥物研發(fā)一直是創(chuàng)新發(fā)展的基石。隨著近幾年新藥研發(fā)政策的不斷放開，在新藥研發(fā)過程中，臨床試驗(yàn)環(huán)節(jié)尤為重要——大約占整個(gè)新藥開發(fā)成本近60%。如何積極地探索利用新的創(chuàng)新手段，提高臨床試驗(yàn)、臨床開發(fā)的效率，以及提高新產(chǎn)品上市的概率，這是所有制藥企業(yè)所面臨的共同的挑戰(zhàn)。與市場增長同步的還有對行業(yè)對藥物研發(fā)臨床研究規(guī)范化和效率要求的不斷提升。

此次峰會(huì)將聚集醫(yī)藥行業(yè)從業(yè)者圍繞如下熱點(diǎn)話題：藥物研發(fā)與臨床試驗(yàn)政策解讀，新藥研發(fā)數(shù)字化，臨床試驗(yàn)數(shù)字化，真實(shí)世界數(shù)據(jù)應(yīng)用，外部合作創(chuàng)新，藥物研發(fā)及臨床試驗(yàn)數(shù)字化合規(guī)管理等，共同探討如何利用數(shù)字技術(shù)，賦能產(chǎn)業(yè)，提高藥品研發(fā)，臨床研究和醫(yī)學(xué)研究以及患者管理的質(zhì)量和效率。?

會(huì)議熱點(diǎn)話題:

• 醫(yī)藥創(chuàng)新與研發(fā)政策法規(guī)解讀
• 《藥物臨床試驗(yàn)質(zhì)量管理規(guī)范》解讀
• AI賦能新藥研發(fā)
• 數(shù)字化CRO轉(zhuǎn)型探索與實(shí)踐
• 智能數(shù)字化臨床試驗(yàn)管理解決方案
• 真實(shí)世界數(shù)據(jù)支持關(guān)鍵性決策
• 真實(shí)世界數(shù)據(jù)推進(jìn)癌癥藥物研發(fā)和精準(zhǔn)醫(yī)療
• ……

峰會(huì)時(shí)間：2021年7月8日-9日

大會(huì)地點(diǎn)：中國 -上海

大會(huì)主辦方：上海希為 ECV International

我們將提供：

• 2天會(huì)議同聲傳譯設(shè)備
• 紙質(zhì)會(huì)刊、APP電子語音材料
• 2天五星級酒店自助午餐券、茶歇以及五星級酒店提供的所有茶點(diǎn)

更多本次峰會(huì)詳細(xì)內(nèi)容，請登錄官方網(wǎng)站：

http://www.ecvinternational.com/PharmaR&DAndClinicalManagement/

聯(lián)系人:?Ciking Zhao

電話：+86 21 8026 0707-803

郵箱：cikingz@ecvinternational.com

?

關(guān)于ECV International

上海希為（ECV International）是亞洲領(lǐng)先的國際高端商業(yè)峰會(huì)及活動(dòng)的主辦和承辦機(jī)構(gòu)，擁有近 200位行業(yè)研究及活動(dòng)策劃、運(yùn)營專家，每年在全球舉辦約40場高端國際峰會(huì)，涉及零售、汽車、紡織、鞋業(yè)、物聯(lián)網(wǎng)、新科技等行業(yè)。

我們?yōu)槌^半數(shù)的財(cái)富 2,000 強(qiáng)企業(yè)提供專業(yè)的商業(yè)會(huì)議及咨詢服務(wù)，每年有超過 6,000 位來自戴姆勒、通用電氣、阿迪達(dá)斯、可口可樂、阿里巴巴、ABB等跨國公司、專業(yè)機(jī)構(gòu)及創(chuàng)新企業(yè)的決策人參加我們的會(huì)議和活動(dòng)。我們的使命是通過提供專業(yè)服務(wù)幫助客戶抓住發(fā)展機(jī)遇、迎接挑戰(zhàn)、實(shí)現(xiàn)全球范圍內(nèi)的可持續(xù)發(fā)展，進(jìn)而影響行業(yè)格局，引領(lǐng)行業(yè)未來

?

China Pharma R&D and Clinical Management Digital Innovation Summit

Drug development has always been the cornerstone of innovation and development. With the continuous liberalization of new drug research and development policies in recent years, clinical trials are particularly important in the process of new drug research and development-accounting for nearly 60% of the entire new drug development cost. How to actively explore and use new innovative methods to improve the efficiency of clinical trials and clinical development, and to increase the probability of new products being launched, is a common challenge faced by all pharmaceutical companies. In keeping with the market growth, the industry has continuously improved the standardization and efficiency requirements of drug R&D and clinical research.

The summit will take place both ONLINE and in-person and gather leaders in the pharmaceutical industry centering the hot topics: policy interpretation of drug R&D and clinical trials, new drug R&D digitalization, clinical trials digitalization, real-world data applications, external cooperation innovation, compliance management for drug R&D and clinical trials, etc. to discuss how to use digital technology to empower the industry and improve the quality and efficiency of drug R&D, clinical and medical research, and patient management.

Highlights:

• Policies and Regulations of Pharmaceutical Innovation and R&D
• Decoding the New Version of GCP
• AI Enables New Drug R&D
• Explorations and Practices in Digital CRO Transformation
• Intelligent Digital Clinical Trial Management Solutions
• Real World Data Supports Critical Decision Making
• Real World Data Advances Cancer Drug R&D and Precision Medicine
• ……

Speakers:

• Ernst & Young
• AstraZeneca
• IQVIA
• Eli Lilly
• Roche Pharmaceuticals
• WuXi AppTec
• GSK
• Sanofi
• ……

Summit time: July 8-9, 2021

Venue: Shanghai, China

Organizer: ECV International

We will provide:

• Simultaneous interpretation devicefor 2-day conference
• Brochure, recordingmaterials
• Two-day buffet lunch coupons, tea breaks and all refreshments provided by five-star hotels

More details, please visit our official website:

http://www.ecvinternational.com/PharmaR&DAndClinicalManagement/

Contact Us:

Ciking?Zhao

Tel: +86 21 8026 0707-803

E-Mail: cikingz@ecvinternational.com

About ECV International

ECV International is a leading organizer and contractor of high-end international business events in Asia, with nearly 200 professionals in industrial research and event planning & execution. Every year, we hold around 40 high-level international summits involved in the fields of vehicle, retail, textile, footwear, IoT, New Science & Technology industry, etc.

We have served more than half of the Fortune 2,000 companies, and every year more than 6,000 delegates from multinational enterprises, specialized organizations and creative companies take part in our events, i.e. Daimler, GE, Adidas, Coca-Cola, Alibaba, ABB, etc.
Our mission is to provide professional services to connect and inform the stakeholders who would be able to shape the industry landscape in the future and to create more value for our clientele through our efforts to help them seize opportunities, meet challenges and achieve sustainable development on a global basis.

?